Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1 | Zendy

Aleksandr I. Ilin | Zendy; Murat E. Kulmanov | Zendy; Ilya S. Korotetskiy | Zendy; Gulshara K. Akhmetova | Zendy; Marina V. Lankina | Zendy; Sergey V. Shvidko | Zendy; Oleg N. Reva | Zendy

Open Access

Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1

Author(s) -

Aleksandr I. Ilin,

Murat E. Kulmanov,

Ilya S. Korotetskiy,

Gulshara K. Akhmetova,

Marina V. Lankina,

Sergey V. Shvidko,

Oleg N. Reva

Publication year - 2015

Publication title -

genome announcements

Language(s) - English

Resource type - Journals

ISSN - 2169-8287

DOI - 10.1128/genomea.01272-15

Subject(s) - reversion , mycobacterium tuberculosis , multiple drug resistance , tuberculosis , biology , drug resistance , whole genome sequencing , drug , genome , population , genetics , microbiology and biotechnology , pharmacology , gene , medicine , phenotype , pathology , environmental health

Complete genome sequence of the multidrug-resistant clinical isolate Mycobacterium tuberculosis SCAID 187.0 containing several drug-resistance mutations is presented. This strain is used in experiments to study genomic and population changes leading to reversion of susceptibility to the 1st line anti-tuberculosis (TB) drugs under the influence of a new medicinal drug FS-1.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research